The Association Between Genetic Variants, Pharmacokinetics, and Infliximab Efficacy in Pediatric Patients With Crohn's Disease in China

Background: Infliximab is an effective therapy for Crohn's disease (CD). Early non-invasive predictors of disease remission allow for modification of treatments. The aim of this study was to investigate the associations between genetic variants, pharmacokinetics, and infliximab efficacy in pedi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Wenhui, Feng, Yan, Ye, Ziqing, Tang, Zifei, Qian, Lai, Wang, Yuhuan, Huang, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8711600/
https://www.ncbi.nlm.nih.gov/pubmed/34966700
http://dx.doi.org/10.3389/fped.2021.744599

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8711600/
https://www.ncbi.nlm.nih.gov/pubmed/34966700
http://dx.doi.org/10.3389/fped.2021.744599

Ejemplares similares